1. Home
  2. YDES vs TRIN Comparison

YDES vs TRIN Comparison

Compare YDES & TRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$11.97

Market Cap

1.1B

Sector

N/A

ML Signal

N/A

Logo Trinity Capital Inc.

TRIN

Trinity Capital Inc.

HOLD

Current Price

$15.20

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
YDES
TRIN
Founded
2013
2007
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
YDES
TRIN
Price
$11.97
$15.20
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$16.00
AVG Volume (30 Days)
110.9K
723.7K
Earning Date
09-30-2025
11-05-2025
Dividend Yield
N/A
13.50%
EPS Growth
N/A
25.79
EPS
N/A
2.17
Revenue
$510,360.00
$268,271,000.00
Revenue This Year
N/A
$29.07
Revenue Next Year
N/A
$13.52
P/E Ratio
N/A
$6.98
Revenue Growth
45.76
30.76
52 Week Low
$5.30
$12.50
52 Week High
$31.00
$16.82

Technical Indicators

Market Signals
Indicator
YDES
TRIN
Relative Strength Index (RSI) N/A 58.79
Support Level N/A $14.47
Resistance Level N/A $15.29
Average True Range (ATR) 0.00 0.22
MACD 0.00 0.09
Stochastic Oscillator 0.00 84.68

Price Performance

Historical Comparison
YDES
TRIN

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

About TRIN Trinity Capital Inc.

Trinity Capital Inc is a closed-end, non-diversified management investment company. The company is engaged in providing debt, including loans and equipment financings, to growth-stage companies, including venture-backed companies and companies with institutional equity investors. Its equipment financings involve loans for general or specific use, including acquiring equipment, secured by the equipment or other assets of the portfolio company.

Share on Social Networks: